Pricing Log in Create free account

Phathom Pharmaceuticals, Inc. (PHAT) vs Prothena Corporation plc (PRTA)

Phathom Pharmaceuticals, Inc. and Prothena Corporation plc are both Biotechnology companies. Phathom Pharmaceuticals, Inc. and Prothena Corporation plc are of similar size ($413.0M and $405.1M). Prothena Corporation plc grew revenue faster over the last twelve months: 347.4% against 86.8%. Phathom Pharmaceuticals, Inc. has the higher net margin (−30.2% vs −45.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Phathom Pharmaceuticals, Inc. leads on 10 and Prothena Corporation plc on 5.

Valuation

Metric PHAT PRTA Biotechnology median
P/E n/m n/m 10.60
P/S 1.62 7.76 9.40
P/B n/m 1.52 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 1.58 2.62 9.02
Earnings yield (19.76%) (5.90%) (32.88%)
Free cash flow yield (4.74%) (7.86%) (23.13%)

Profitability

Metric PHAT PRTA Biotechnology median
Gross margin 80.68% 100.00% 68.51%
Operating margin (9.26%) (64.64%) 0.00%
Net margin (30.19%) (45.43%) 0.00%
Free cash flow margin (7.65%) (61.03%) 0.00%
Return on equity 21.55% (8.50%) (51.96%)
Return on assets (28.36%) (7.53%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PHAT PRTA Biotechnology median
Revenue growth (TTM) 86.75% 347.44% 6.76%
EPS growth (last fiscal year) 42.72% (99.56%) 29.88%
Revenue growth, 5-year CAGR — 62.56% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PHAT PRTA Biotechnology median
Debt to equity (0.48) 0.00 0.00
Current ratio 1.76 23.95 4.97
Net debt to EBITDA (0.51) 1.46 1.01

Dividend

Metric PHAT PRTA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric PHAT PRTA Biotechnology median
Market cap 412.96m 405.05m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack